Sensyne Health PLC
LSE:SENS
Sensyne Health PLC
LSE:SENS
Price:
0.35 GBX
-33.33%
Market Closed
Updated:
May 21, 2024
Sensyne Health PLC
Research & Development
|
Sensyne Health PLC
Research & Development Peer Comparison
Comparables:
RENX
CRW
IUG
INS
EMIS
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sensyne Health PLC
LSE:SENS
|
Research & Development
-£16m
|
CAGR 3-Years
-92%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Renalytix PLC
LSE:RENX
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Craneware PLC
LSE:CRW
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Intelligent Ultrasound Group PLC
LSE:IUG
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Instem PLC
LSE:INS
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EMIS Group PLC
LSE:EMIS
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Sensyne Health PLC's Research & Development?
Research & Development
-16m
GBP
-16m
GBP
Based on the financial report for Apr 30, 2021, Sensyne Health PLC's Research & Development amounts to -16m GBP.
What is Sensyne Health PLC's Research & Development growth rate?
Research & Development CAGR 3Y
-92%
-92%
Over the last year, the Research & Development growth was -44%. The average annual Research & Development growth rates for Sensyne Health PLC have been -92% over the past three years .
You don't have any saved screeners yet
